Mechanism-driven metabolic reprogramming
Our approach goes beyond symptom management. We target the fundamental cellular pathways that regulate metabolism, energy production, and inflammatory response.
By understanding and modulating these pathways at the molecular level, we develop therapies that address the root causes of metabolic and neurodegenerative disorders.
Three interconnected pathways
Our therapeutic strategy targets multiple cellular mechanisms that work synergistically to restore metabolic health.
Mitochondrial Function
Mitochondria are the powerhouses of cells, and their dysfunction is central to metabolic disease. Our approach enhances mitochondrial biogenesis, improves electron transport chain efficiency, and reduces oxidative stress to restore cellular health.
Increased mitochondrial biogenesis
Enhanced oxidative phosphorylation
Reduced mitochondrial ROS production
Improved mitochondrial quality control
Cellular Energy Regulation
We target key metabolic pathways that control how cells generate and utilize energy. By modulating AMP-activated protein kinase (AMPK) and related signaling cascades, our therapies restore cellular energy balance and enhance metabolic flexibility.
Activation of AMPK signaling
Enhanced glucose uptake and utilization
Improved fatty acid oxidation
Restoration of metabolic homeostasis
Inflammatory Signaling Pathways
Chronic inflammation drives metabolic dysfunction and tissue damage. We modulate key inflammatory pathways including NF-κB and inflammasome signaling to reduce systemic inflammation and protect metabolic tissues.
Inhibition of NF-κB activation
Suppression of NLRP3 inflammasome
Reduced pro-inflammatory cytokine production
Protection against metabolic inflammation